bismuth subsalicylate 262 MG Powder for Oral Suspension

RxCUI
1721449
RxNorm name
bismuth subsalicylate 262 MG Powder for Oral Suspension
Term type
SCD
Status
Active
Updated
2026-11-02 18:15:43

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122015
Active start
122015
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
bismuth subsalicylate262 MG / 1 EACHbismuth subsalicylatebismuth subsalicylate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Powder for Oral Suspension1540456

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
bismuth subsalicylate19478

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRbismuth subsalicylate 262 MG Powder for Oral Suspension1NAMES
RxNorm Namebismuth subsalicylate 262 MG Powder for Oral Suspension1NAMES
TTYSCD1ATTRIBUTES
RxCUI17214491CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Estomaquil PolvoBISMUTH SUBSALICYLATEProMex LLCcf94c99a-c489-45ec-bb13-3e6959e377de2023-11-29WarningsExact identifier
rxcui: 1721449

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
cf94c99a-c489-45ec-bb13-3e6959e377debismuth subsalicylate 262 MG Powder for Oral Suspension [PSN] · bismuth subsalicylate 262 MG Powder for Oral Suspension [SCD]24Estomaquil ® Polvo20231129
e272c1cf-9793-0abd-e053-2995a90a2229bismuth subsalicylate 262 MG Powder for Oral Suspension [PSN] · bismuth subsalicylate 262 MG Powder for Oral Suspension [SCD]21Estomaquil ® Polvo20220627

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
FDASPLD001729BismuthCHEMhas_chemical_structurebismuth subsalicylate
FDASPLN0000180183BismuthEPChas_epcbismuth subsalicylate
MEDRTD001729BismuthCHEMhas_ingredientbismuth subsalicylate
MEDRTD009942Organometallic CompoundsCHEMhas_ingredientbismuth subsalicylate
MEDRTD012459SalicylatesCHEMhas_ingredientbismuth subsalicylate
MEDRTD001778Blood Coagulation DisordersDISEASEci_withbismuth subsalicylate
MEDRTD002644ChickenpoxDISEASEci_withbismuth subsalicylate
MEDRTD003967DiarrheaDISEASEmay_treatbismuth subsalicylate
MEDRTD004342Drug HypersensitivityDISEASEci_withbismuth subsalicylate
MEDRTD004405Dysentery, BacillaryDISEASEmay_treatbismuth subsalicylate
MEDRTD004415DyspepsiaDISEASEmay_treatbismuth subsalicylate
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatbismuth subsalicylate
MEDRTD006471Gastrointestinal HemorrhageDISEASEci_withbismuth subsalicylate
MEDRTD016481Helicobacter InfectionsDISEASEmay_treatbismuth subsalicylate
MEDRTD009325NauseaDISEASEmay_treatbismuth subsalicylate
MEDRTD011263Pregnancy Trimester, ThirdDISEASEci_withbismuth subsalicylate
MEDRTD013272Stomach DiseasesDISEASEmay_treatbismuth subsalicylate
MEDRTD014777Virus DiseasesDISEASEmay_treatbismuth subsalicylate
MEDRTN0000000226Acid-Base ActivityMOAhas_moabismuth subsalicylate
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moabismuth subsalicylate
MEDRTN0000009724Inhibition Gastric Acid SecretionPEhas_pebismuth subsalicylate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESACTIVATED01/30/2024
ATTRIBUTESAVAILABLE_STRENGTH262 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable Synonymbismuth subsalicylate 262 MG Powder for Oral Suspension